Press Enter to search · ESC to close

Macro

Fosun Pharma Chair Proposes A-Share Buyback of Up to RMB 500 Million

Chen Yuqing, chairman of Fosun Pharma, proposed a buyback of the company’s A-shares via centralized bidding, with total funding of no less than RMB 250 million and no more than RMB 500 million. The buyback price will not exceed 150% of the average price over the 30 trading days before the board approves the plan, and the program will run for up to 12 months. Repurchased shares will be used for convertible bond conversion, equity incentives and/or employee stock ownership plans.

Share

Related News

新云社 share card
Long-press image above → Save to Photos / Share
Pitch us Feedback